Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023418 (
leukemia
)
93,477
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A study of the effects of human leukocyte and lymphoblastoid
interferon
preparation on the growth of normal, immune and malignant haemopoietic cells has been carried out. At a standard dose of 10,000 U/ml, incorporation of tritiated thymidine ([3H] TdR) was reduced by 7-92% of control values, and cell survival by 35-82% in acute myelogenous
leukaemia
cell cultures, whereas in normal bone-marrow cultures
interferon
showed a 58-62% reduction in [3H] TdR uptake but only up to 13% reduction in cell survival. [3H] TdR incorporation by MLC-stimulated lymphocytes was also significantly reduced by
interferon
but the blastogenic response to PHA was not. These effects of
interferon
were shown to be dose-dependent. The problems of using
interferon
in the treatment of AML in the light of these findings are discussed.
...
PMID:Growth inhibitory effects of interferon on normal and malignant human haemopoietic cells. 14 95
Herpesvirus saimiri (HVS) is an oncogenic virus for a variety of nonhuman primates. HVS does not produce overt disease upon inoculation in the natural host (squirrel monkey) but consistently induces neoplasms including lymphomas and lymphocytic leukemias in 4 other species of monkeys. Various drugs inhibit replication of HVS in vitro including cytosine arabinoside and adenine arabinoside. In addition, the lymphoma and
leukemia
induced in owl monkeys responds to vincristine and prednisolone, cyclophosphamide, cytosine arabinoside, and human
interferon
. Of the various chemical carcinogens studied, the antitumor agent procarbazine induces neoplasms in a variety of species including monkeys. Thus far this compound has induced acute myelogenous leukemia (AML), lymphoma, and hemangiosarcomas in macaques. We have induced primary liver tumors in macaques with several nitrosamines and aflatoxin B1 and these tumors produce alpha-fetoprotein (AFP) which can be assayed for both diagnosis and therapy. Thus far, therapy of hepatocellular carcinoma has been most successful with surgical resection; and the tumor mass and serum AFP have been less responsive to single agent chemotherapy. These nonhuman primate models are useful for an understanding of the cause, diagnosis, prevention, and treatment of the human disease.
...
PMID:Nonhuman primate models for lymphoma, leukemia, and other neoplasms. 16 36
The nature of Herpesvirus saimiri-induced disease in owl monkeys is described with emphasis on those biological parameters useful in monitoring the disease. These parameters are lymphocyte response to general mitogens, lymphocyte-infective centers, and antibody to virus-associated early antigen. Human
interferon
was used in treating owl monkeys with virus-induced
leukemia
. In 2 animals evidence was obtained that suggested a positive antileukemic effect.
...
PMID:Pilot studies with human interferon in Herpesvirus saimiri-induced lymphoma in owl monkeys. 17 32
In AKR mouse cells chronically infected with a murine
leukemia
virus, treatment with
interferon
for nine days resulted in sustained inhibition of extracellular production of murine
leukemia
virus but no inhibition of viral intracellular p30 antigen or of reverse transcriptase. Removal of
interferon
resulted in rapid reversal of these effects. Interferon-treated mouse L-cells were infected with high multiplicities of vesicular stomatitis virus or herpes simplex virus type 1. Infectious virus and intracellular viral antigen were rapidly eliminated from the
interferon
-treated cultures infected with herpes simplex virus. In cultures infected with vesicular stomatitis virus, titers of virus remained low in
interferon
-treated cells, but after about two weeks they rose rapidly and the cultures were destroyed. If treatment with
interferon
was reinstituted as late as nine days after primary infection, infectious vesicular stomatitis virus was eliminated, and there was no evidence for survival of the viral genome in these cultures. In the cultures infected with murine
leukemia
virus, inhibition of production of virus by treatment with
interferon
was possible, but the viral genome was not eliminated. In cells acutely infected with vesicular stomatitis virus or herpes simplex virus, however, the viral genomes were apparently eliminated from cultures treated with
interferon
.
...
PMID:Persistence of the viral genome in interferon-treated cells infected with oncogneic or nononcogenic viruses. 18 Feb 9
The Sendai virus-induced
interferon
(IF) production by partially purified human leucocyte suspensions of normal donors and of leukaemic patients have been investigated in vitro. (i) An increased production was observed with leucocytes taken from patients suffering from chronic myelogenous
leukaemia
(CML) during exacerbation, but the production was approximately normal with cells taken during remission. (ii) IF production was not influenced by large doses of cytostatics (DBM, 5-FU, FUDR, 5-HU, 6-MP, cyclophosphamide) irrespective of whether normal or CML leucocytes were used. (iii) In contrast, production was inhibited in both systems by inhibitors of RNA or protein synthesis (actinomycin D, puromycin, cycloheximide). (iv) CML leucocytes produced IF for a prolonged period of time as compared to normal leucocytes. (v) Leucocytes from children with acute blastic
leukaemia
and those from adults with chronic lymphoid or acute paramyeloblastic
leukaemia
produce, in contrast to normal leukocytes, approximately as much IF in the absence as in the presence of serum. It is concluded that the Sendai virus-induced IF synthesis in CML leucocytes requires de novo protein synthesis.
...
PMID:Interferon production by human leukaemic leucocytes. 18 Jul 56
Silica, an agent predominantly toxic for macrophages, inoculated i.v. to Friend leukemia virus (FLV)-infected mice, blocks the FLV-leukemosuppressive effects of chlorite-oxidized oxyamylose (COAM)-statolon treatment. FLV-infected, COAM-statolon-treated mice that have received silica and have failed to suppress FLV
leukemia
produced normal amounts of
interferon
, but did not make antibodies cytotoxic for FLV leukemic cells. Transfer of untreated spleen cells, splenic T cells, or thymocytes from mice with suppressed FLV erythroleukemia to FLV-infected mice treated with silica and COAM-statolon restores the humoral immune response to FLV antigens and results in leukemosuppression. Thus, T lymphocytes from mice with suppressed erythroleukemia participate in FLV leukemosuppression either directly as effector cells, or indirectly as helper cell in the production of antibodies to FLV antigens.
...
PMID:Use of silica to identify host mechanisms involved in suppression of established Friend virus leukemia. 18 37
Scanning electron microscopy of AKR cells chronically infected with AKR mouse
leukaemia
virus revealed that the number of budding virions was greatly increased in
interferon
-treated cells. These results, together with previous biochemical findings, suggest that in this system,
interferon
inhibits a late stage of virus assembly or release.
...
PMID:Interferon inhibits mouse leukaemia virus release: an electron microscope study. 19 Mar 48
Inhibitors of elongation steps in protein synthesis such as cycloheximide and anisomycin mimic
interferon
treatment in that they specifically inhibit the synthesis of certain viral proteins. These specific effects are seen only at very low concentrations of the antibiotics, under conditions where host cellular protein synthesis, as well as cell viability, are not severely reduced. A qualitatively as well as quantitatively close correlation between the effects of the two types of agents has been established for encephalomyocarditis virus, vesicular stomatitis virus and murine
leukemia
virus protein synthesis. It is concluded that one of the primary mechanisms of
interferon
action may be a nonspecific retardation of one or more elongation steps, and that this may be sufficient to account for its effects on the replication of certain viruses such as encephalomyocarditis and vesicular stomatitis viruses.
...
PMID:Specificity of interferon action in protein synthesis. 21 87
The effect of long-term administration of
interferon
in New Zealand Black and New Zealand Black/New Zealand White F1 hybrid mice was studied. Treatment with moderate doses of
interferon
(10(4) units, five times weekly for 8 weeks) did not depress murine
leukemia
virus gp69/71 levels in serum and spleen, nor p30 levels in the spleen. Interferon given at 10(5.1) units (three times weekly for 37 weeks) caused an increased incidence of anti-erythrocyte antibodies in New Zealand Black mice. Finally, the hybrid mice given
interferon
at 10(6.0) units (three times weekly for 33 weeks) had increased renal immune complex deposits and increased incidences of proteinuria and anemia.
...
PMID:Interferon treatment of NZB mice: accelerated progression of autoimmune disease. 21 92
Interferon treatment appears to induce a number of changes in the plasma membrane of uninfected cells. Interferon treatment altered the surface exposure of gangliosides of both Ly and KB cell membranes. The differences were found in the amount and pattern of incorporation of tritium after galactose oxidase treatment. In AKR,C- (AKR-2B) mouse cells, not only was there an apparent increase in the number of intramembranous particles in response to treatment with
interferon
but also the kinetics of the increase followed that of the establishment of the antiviral activity. The buoyant density of plasma membrane was also found to be significantly increased in
interferon
-treated cells. Moloney murine
leukemia
virus produced in
interferon
-treated mouse thymus and bone marrow cells had a high particle to infectivity ration. This virus contained a prominent glycoprotein with a molecular weight of about 85,000. This large glycoprotein was only a very minor component of Moloney
leukemia
virus produced in control TB cells and might be an uncleaved precursor to gp 69-71.
...
PMID:Membrane alterations following interferon treatment. 21 15
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>